Helping you make wiser investment decisions

Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa

March 15, 2022 ntaylor



Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa
ntaylor
Tue, 03/15/2022 – 09:04



Source link